Assort Health Secures $102 Million Series Funding to Scale Its Agentic AI Platform in Healthcare Access
- Oct 6
- 2 min read
Assort Health, the comprehensive patient experience platform powered by specialty-specific agentic AI, recently announced a massive injection of capital aimed at solving some of healthcare’s most enduring frustrations. The company has successfully closed a $76 million Series B financing round, led by Lightspeed Venture Partners, bringing its total funding raised to date to $102 million. This significant investment will be used to accelerate the development of its platform, Assort OS, and expand its growing team.
The funding arrives as Assort Health continues its rapid growth, addressing a universal, frustrating problem: the nightmare of scheduling a doctor’s appointment. Today, patients often endure endless hold music, face disconnections, require multiple transfers, and must constantly reshare intake data when calling their providers. According to sources, U.S. adults currently spend the equivalent of an entire workday each month navigating healthcare needs for themselves and their families. This results in missed appointments and incomplete care.
Assort Health’s mission is to leverage agentic AI to remove these barriers to care. The company’s AI agents facilitate a seamless and pleasant experience, transforming patient touchpoints beyond mere scheduling, including lab tests, prescription renewals, and physician referrals. Assort Health integrates its omnichannel AI solutions into existing Electronic Health Record (EHR) and Practice Management (PM) workflows, using AI and natural language processing to resolve inquiries without tying up medical call center teams.
The impact of this technology is already profound. Customers utilizing Assort’s technology have reported seeing 89% shorter patient call wait times. Hundreds of leading healthcare organizations are achieving 98% resolution rates and PSAT scores above 94%.
For healthcare organizations, these solutions are critical. Providers are currently battling increasing costs, reduced reimbursements, and persistent shortages of healthcare workers, leading to overburdened front office operations managing towering call volumes. Galym Imanbayev, MD of Lightspeed Venture Partners, noted that Assort Health is leading the "re-platforming of patient engagement into the AI-native era".
By successfully managing inbound calls and simplifying internal operations, Assort Health enables a critical shift in the healthcare landscape. As Dr. Titus Abraham, a physician at Annapolis Internal Medicine, suggests, Assort Health allows the healthcare system to move away from being reactive and toward a proactive patient-centric system. The new Series B funding positions Assort Health to extend its lead role in using AI to eliminate the stress tied to accessing necessary care.
🔖 Sources
